Endometriosis Awareness Month / March 2020
Accelsiors proudly supports Endometriosis Awareness Month, observed in March across the globe, with a mission to raise awareness of a disease, which affects millions of women worldwide.
Endometriosis, a chronic and painful condition, is generally acknowledged that affects an estimated 10% of all women during their reproductive years. This equates to an estimated 176 million women throughout the world, who have to deal with the symptoms of endometriosis during the prime years of their lives. Since there is no cure for this disease, at the moment, the endometriosis is one of the largest women’s health crisis of our time.
You can discover more about the Endometriosis Awareness Month at the global forum for news and information about the disease at endometriosis.org, and take time to review facts empower women to make informed decisions about treatment options.
As a leader CRO in Woman’s Health clinical trials for a wide range of therapeutic areas and indications, we are committed to support Pharma industry in finding a new and successful treatment for women with Endometriosis. We stand together in support of women who suffer willing to improve life for those affected by this terrible disease.
Accelsiors has been highly involved in endometriosis research; successfully collaborating with pharma and biotech companies from both the EU and the USA. We have extensive knowledge and experience on GnRH agonists and antagonists. Accelsiors has conducted endometriosis studies from Phase I to phase III, which studies are being supervised by highly experienced in Women’s Health senior staff, working together for more than 10 years. Moreover, we keep close collaboration with experienced investigators in endometriosis clinical trials.
Read more about our professional background in clinical drug development!